Rx for Pricey Drugs: Assistance Programs and Bargain Prices

Drugmakers and retail chains offer meds at bargain prices. But are they worth it?















Share on Tumblr


Other retailers have stepped up with free antibiotic deals, which provide common antibiotics at no cost to consumers regardless of insurance status or co-pays. The Midwest grocery chain Meijer launched its program in 2006 and filled a million prescriptions of its seven free antibiotics in the first year. Since then, Publix, Schnucks and other chains have started ongoing free antibiotic programs. This winter, even more retailers, including ShopRite, Wegmans and Royal Ahold (the parent company of the Giant and Stop & Shop chains), have jumped on board to offer select antibiotics gratis through March.

Though most health officials praise the efforts, some fret that providing cheap antibiotics may open the door to more antibiotic-resistant infections.

"While we appreciate the fact that many retailers are trying to assist customers," Hicks says, "there is some concern that this might lead to inappropriate antibiotic use." Although viral infections such as the common cold and flu don't respond to antibiotics, she says, tens of millions of antibiotics get prescribed for exactly those uses by doctors under pressure from patients—or patient's parents—to hand over scrips for them. Such overuse ups the resistance of bacterial infections to antibiotics, which has triggered potentially deadly superbugs such as MRSA (methicillin-resistant Staphylococcus aureus), or "staph".

The length of some discounted prescriptions also raises flags for Hicks, who works with the CDC's Get Smart program, which is designed to educate the public about the proper use of antibiotics.

A Spoonful of Samples  Millions of Americans have been able to skip a $4 pharmacy trip altogether and get free drugs straight from their doctors. Pharmaceutical companies distribute more than $16 billion in free drug samples annually to medical providers. PhRMA in its literature pegs this practice as "an important part of the health care safety net for low-income and uninsured patients," citing a 2003 study from the Journal of Family Practice. A study published in the AJPH last year, however, found that the bulk of free samples were distributed to patients who already had insurance coverage and were more likely to be financially able to purchase a prescription of the drug.

At the end of the day, says Stephanie Woolhandler, an associate professor of medicine at Harvard Medical School and co-author of the AJPH study, free samples and industry assistance programs are "mostly a way of diffusing much of the anger Americans feel about drug prices…. It's not an overall solution to this problem."

So what is the remedy? "Pharmaceutical companies need to change their business model," Matheis says. And, she says, "We need to have a system where everybody is covered, whether it's private insurance coverage or government-sponsored coverage."

In the meantime, The Help Is Here Express buses continue to crisscross the country to help staunch the growing need of people who are having a hard time paying for their prescriptions.



2 Comments

Add Comment
View
  1. 1. pgtruspace 10:54 PM 2/13/09

    At some point the retail price of pharmaceuticals must be set so that the instiutional price to governmental and insurance payers can be determined. Almost all of retail trade is to Americans that pay their own bills, everyone else buys at large discount. But someone has to pay full retail to set the real price, the discount price. Discount sales are by far, most of the sales volume and profit. Give away of a few million$ is nothing per billion$ in sales. Ask any any dope pusher. Unfortunately people that pay their own bills are to poor to have insurance and to proud to be on the dole.

    Reply | Report Abuse | Link to this
  2. 2. jaiagreen 09:38 PM 2/16/09

    It's stupid to blame free antibiotic programs for doctors' prescribing practices. In fact, I suspect that such programs might help combat antibiotic resistance by making sure patients take the full dose. as opposed to a reduced dose that is more likely to select against only the most susceptible bugs.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Science Jobs of the Week

Email this Article

Rx for Pricey Drugs: Assistance Programs and Bargain Prices

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X